Bridgefront Capital’s Boston Scientific BSX Stock Holding History

Bridgefront Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$399K	Sell	9,338 -21,292	-70%	-$1.16M	0.11%	307
2026 Q1	$1.92M	Buy	30,630 +6,862	+29%	+$549K	0.48%	45
2025 Q4	$2.27M	Sell	23,768 -2,550	-10%	-$250K	0.57%	27
2025 Q3	$2.57M	Buy	26,318 +12,471	+90%	+$1.29M	0.76%	7
2025 Q2	$1.49M	Sell	13,847 -6,293	-31%	-$637K	0.39%	42
2025 Q1	$2.03M	Buy	+20,140	New	+$2.03M	0.59%	13
2024 Q4	–	Sell	-6,216	Closed	-$521K	–	595
2024 Q3	$521K	Buy	+6,216	New	+$490K	0.2%	174
2023 Q3	–	Sell	-16,482	Closed	-$892K	–	410
2023 Q2	$892K	Buy	16,482 +12,224	+287%	+$638K	0.48%	34
2023 Q1	$213K	Sell	4,258 -5,291	-55%	-$249K	0.13%	319
2022 Q4	$442K	Buy	+9,549	New	+$413K	0.31%	120
2021 Q1	–	Sell	-56,663	Closed	-$2.04M	–	690
2020 Q4	$2.04M	Buy	+56,663	New	+$2.04M	0.7%	5

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bridgefront Capital's BSX Position: Q2 2026 in Review

Bridgefront Capital reduced its Boston Scientific (BSX) stake by 70% in Q2 2026, selling an estimated $1.16M and leaving 9,338 shares worth $399K. The position accounts for 0.11% of the portfolio, ranked #307.

Bridgefront Capital first reported a position in BSX in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.57M in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Bridgefront Capital held 9,338 shares of Boston Scientific worth $399K as of Q2 2026.
Bridgefront Capital sold 21,292 Boston Scientific shares in Q2 2026, an estimated $1.16M.
Boston Scientific made up 0.11% of Bridgefront Capital's portfolio in Q2 2026, its #307 holding.
Bridgefront Capital first reported a position in Boston Scientific in Q4 2020 and has held it in 11 quarters since.
Bridgefront Capital's Boston Scientific position peaked at $2.57M in Q3 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.